Exact Sciences (EXAS) News Today $59.40 +3.29 (+5.86%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Brokerages Set Exact Sciences Co. (NASDAQ:EXAS) PT at $72.94December 17, 2024 | americanbankingnews.comTidal Investments LLC Acquires 21,683 Shares of Exact Sciences Co. (NASDAQ:EXAS)Tidal Investments LLC raised its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 172.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 34,275 shares of the medical research company's stock after buying an additional 21,683December 16, 2024 | marketbeat.comToronto Dominion Bank Sells 2,994,169 Shares of Exact Sciences Co. (NASDAQ:EXAS)Toronto Dominion Bank lowered its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 99.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,628 shares of the medical research company's stock after selDecember 16, 2024 | marketbeat.comPublic Employees Retirement System of Ohio Sells 8,728 Shares of Exact Sciences Co. (NASDAQ:EXAS)Public Employees Retirement System of Ohio trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 11.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 66,593 shares of the medical researDecember 15, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eighteen research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and sevenDecember 14, 2024 | marketbeat.comExact Sciences: Profitability Remains ElusiveDecember 13, 2024 | seekingalpha.comBank of America Cuts Exact Sciences (NASDAQ:EXAS) Price Target to $72.00Bank of America reduced their target price on shares of Exact Sciences from $75.00 to $72.00 and set a "buy" rating for the company in a report on Friday.December 13, 2024 | marketbeat.comExact Sciences (EXAS) Gets a Buy from TD CowenDecember 12, 2024 | markets.businessinsider.comGroupama Asset Managment Takes $821,000 Position in Exact Sciences Co. (NASDAQ:EXAS)Groupama Asset Managment bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,204,952 shares of the medical research company's stoDecember 10, 2024 | marketbeat.com30,579 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Zacks Investment ManagementZacks Investment Management bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 30,579 shares of the medical researchDecember 10, 2024 | marketbeat.comAAPA Awarded Grant from Exact Sciences to Improve Colorectal Cancer Screening RatesDecember 9, 2024 | globenewswire.comPier Capital LLC Makes New $5.52 Million Investment in Exact Sciences Co. (NASDAQ:EXAS)Pier Capital LLC purchased a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 81,036 shares of the medical research company's stock,December 8, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Stock Holdings Raised by Soros Fund Management LLCSoros Fund Management LLC boosted its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 68.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 378,590 shares of the medical research company's stDecember 6, 2024 | marketbeat.comPolar Asset Management Partners Inc. Acquires 45,800 Shares of Exact Sciences Co. (NASDAQ:EXAS)Polar Asset Management Partners Inc. raised its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 203.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 68,300 shares of the medical reseaDecember 5, 2024 | marketbeat.comCerity Partners LLC Has $1.11 Million Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)Cerity Partners LLC increased its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 193.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,329 shares of the medical research company's stock after buying anDecember 5, 2024 | marketbeat.comExact Sciences Corporation (EXAS) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)December 4, 2024 | seekingalpha.comCinctive Capital Management LP Acquires Shares of 8,510 Exact Sciences Co. (NASDAQ:EXAS)Cinctive Capital Management LP bought a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 8,510 shares of the medical research company's stock, valuedDecember 4, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Grows Stock Position in Exact Sciences Co. (NASDAQ:EXAS)The Manufacturers Life Insurance Company raised its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 35.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 136,592 shares of the medical research company's stocDecember 4, 2024 | marketbeat.comExact Sciences Corporation (EXAS) Citi's 2024 Global Healthcare Conference (Transcript)December 3, 2024 | seekingalpha.comBeacon Investment Advisory Services Inc. Sells 8,916 Shares of Exact Sciences Co. (NASDAQ:EXAS)Beacon Investment Advisory Services Inc. reduced its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 20.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 33,985 shares ofDecember 3, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $91.27 Million Stock Position in Exact Sciences Co. (NASDAQ:EXAS)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 24.0% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 1,339,897 shares of the medical research company's stock aDecember 3, 2024 | marketbeat.comExact Sciences and Lil Jon Partner on “Get Low #2” Campaign to Encourage Colon Cancer ScreeningDecember 2, 2024 | businesswire.comExact Sciences Co. (NASDAQ:EXAS) Stock Holdings Lifted by BRITISH COLUMBIA INVESTMENT MANAGEMENT CorpBRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 215.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 109,815 shares of the medical research company's stock aDecember 2, 2024 | marketbeat.comFred Alger Management LLC Purchases Shares of 30,536 Exact Sciences Co. (NASDAQ:EXAS)Fred Alger Management LLC acquired a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 30,536 shares of the medical research company's stock, valuedDecember 2, 2024 | marketbeat.comErste Asset Management GmbH Purchases Shares of 392,139 Exact Sciences Co. (NASDAQ:EXAS)Erste Asset Management GmbH acquired a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 392,139 shares of the medical research company's stock, valuedDecember 1, 2024 | marketbeat.comBellevue Group AG Buys 290,585 Shares of Exact Sciences Co. (NASDAQ:EXAS)Bellevue Group AG increased its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 25.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,449,465 shares of the medical research company's stock after acquiring an aDecember 1, 2024 | marketbeat.comWasatch Advisors LP Decreases Holdings in Exact Sciences Co. (NASDAQ:EXAS)Wasatch Advisors LP trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 13.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 437,873 shares of the medicDecember 1, 2024 | marketbeat.comNorthwest & Ethical Investments L.P. Lowers Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)Northwest & Ethical Investments L.P. reduced its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 55.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 28,870 shares of the medical research company's stock after selling 36,242 shares during the periNovember 30, 2024 | marketbeat.comBraidwell LP Decreases Stake in Exact Sciences Co. (NASDAQ:EXAS)Braidwell LP trimmed its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 74.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 286,178 shares of the medical research company's stock afterNovember 29, 2024 | marketbeat.comSpyglass Capital Management LLC Has $95.17 Million Position in Exact Sciences Co. (NASDAQ:EXAS)Spyglass Capital Management LLC trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 1.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,397,093 shares of the medical research company's stock after sellinNovember 29, 2024 | marketbeat.comFisher Asset Management LLC Has $8.37 Million Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)Fisher Asset Management LLC cut its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 22.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 122,902 shares of the medical research company's stock after selling 36,302 shares during theNovember 29, 2024 | marketbeat.comEXAS reaffirms stock target, rating held on amid CMS price boostNovember 28, 2024 | uk.investing.comCharles Schwab Investment Management Inc. Purchases 45,015 Shares of Exact Sciences Co. (NASDAQ:EXAS)Charles Schwab Investment Management Inc. increased its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 3.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,292,090 shares of the medical resNovember 28, 2024 | marketbeat.com51,700 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Soros Capital Management LLCSoros Capital Management LLC purchased a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,700 shares of theNovember 27, 2024 | marketbeat.comWhat 19 Analyst Ratings Have To Say About Exact SciencesNovember 26, 2024 | benzinga.comExact Sciences Gains Price Stability with Cologuard Plus Test Price Increase, Boosting Buy RatingNovember 26, 2024 | markets.businessinsider.comExact Sciences (EXAS) Receives a Buy from Stifel NicolausNovember 26, 2024 | markets.businessinsider.comWhy Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)November 26, 2024 | benzinga.comPiper Sandler Releases a Buy Rating on Exact Sciences (EXAS)November 26, 2024 | markets.businessinsider.comExact Sciences’ Revenue Boost: Impact of CMS Pricing Decision on Cologuard PlusNovember 26, 2024 | markets.businessinsider.comExact Sciences to Participate in December Investor ConferencesNovember 26, 2024 | businesswire.comExact Sciences to present 10 abstracts on Precision Oncology portfolio at SABCSNovember 25, 2024 | markets.businessinsider.comExact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024November 25, 2024 | businesswire.comBrokers Offer Predictions for Exact Sciences FY2024 EarningsExact Sciences Co. (NASDAQ:EXAS - Free Report) - Equities researchers at William Blair lowered their FY2024 earnings estimates for Exact Sciences in a report issued on Thursday, November 21st. William Blair analyst A. Brackmann now forecasts that the medical research company will post earnings peNovember 25, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. cut its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 28.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 41,971 shares of the medical researcNovember 24, 2024 | marketbeat.comB. Metzler seel. Sohn & Co. Holding AG Acquires New Holdings in Exact Sciences Co. (NASDAQ:EXAS)B. Metzler seel. Sohn & Co. Holding AG bought a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 32,194 shares of the medical research company's stock, valueNovember 22, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. raised its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 59.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 335,705 shares of the medical research company's stock after purchasing an additNovember 21, 2024 | marketbeat.comJennison Associates LLC Has $60.26 Million Stake in Exact Sciences Co. (NASDAQ:EXAS)Jennison Associates LLC reduced its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 884,659 shares of the medical research company's stock after selling 30,775 shares during the quartNovember 21, 2024 | marketbeat.comSwiss National Bank Increases Holdings in Exact Sciences Co. (NASDAQ:EXAS)Swiss National Bank increased its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 2.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 547,680 shares of the medical research comNovember 21, 2024 | marketbeat.comExact Sciences (EXAS) Receives a Buy from JefferiesNovember 20, 2024 | markets.businessinsider.com Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. EXAS Media Mentions By Week EXAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAS News Sentiment▼0.730.60▲Average Medical News Sentiment EXAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAS Articles This Week▼49▲EXAS Articles Average Week Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Biogen News United Therapeutics News Neurocrine Biosciences News Incyte News BioMarin Pharmaceutical News Exelixis News Repligen News Madrigal Pharmaceuticals News Halozyme Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
